Exosome Diagnostics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 07, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Company Description
- Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.
- Market
- Molecular Diagnostics
- Location
- New York, New York, USA
- Coinvestors
- Arcus Ventures, Blue Ridge Capital, CD Ventures, Forbion Capital Partners, NGN Capital, QIAGEN, Tiger Management